GRAIL stock dives nearly 50% after UK Galleri trial misses key goal, raising FDA questions
GRAIL, Inc. shares tumbled 49.8% to $51.00 during Friday afternoon trading, hitting a session low of $45.51 earlier amid heavy volume.
GRAIL stock drops in New York session as Galleri FDA filing timeline returns to focus
GRAIL Inc shares were down 3.3% at $84.95 in afternoon trading on Tuesday, after earlier touching $84.77.